TARGET SERVING COVID-19: PERSONAL CARE, HYGIENE PRODUCTS, AND PHARMA

Ascendis Capital has secured an LOI to acquire a Personal Care, Hygiene Products, and Pharmaceutical company. The target presents high margins and is resistant to recession showing growth during Covid-19. It manufactures and packages liquid and semi-solid cosmetics, hygiene and pharmaceutical products it has Mexican and American certificates to export. It serves B2B big pharma contracts as well as having its own health, beauty, and wellness products of natural origin. It has its own patents and trademarks. Company is growing driven by USMCA, e-commerce, consumer trends, and Covid-19. This company is based in Mexico City and reached sales of US$ 15.8M and EBITDA of US$ 3.0M (19%). The deal has multiple arbitrage, fundamentals, and leverage potential. The LOI and proposed funding structure are: EV of 5.4x EBITDA = US$ 16.2M, of which US$ 5.0M are debt and US$ 11.2M is equity. We have advanced due diligence and are looking for investors. In case you are interested, please contact me: [redacted]



share: